Global CRO Services for BioPharma Market Growth (Status and Outlook) 2024-2030

Global CRO Services for BioPharma Market Growth (Status and Outlook) 2024-2030

Contract Research Organizations (CROs) provide a range of services to biopharmaceutical companies, helping them streamline the drug development process, from discovery through to regulatory approval and beyond.

The global CRO Services for BioPharma market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “CRO Services for BioPharma Industry Forecast” looks at past sales and reviews total world CRO Services for BioPharma sales in 2022, providing a comprehensive analysis by region and market sector of projected CRO Services for BioPharma sales for 2023 through 2029. With CRO Services for BioPharma sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CRO Services for BioPharma industry.

This Insight Report provides a comprehensive analysis of the global CRO Services for BioPharma landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CRO Services for BioPharma portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CRO Services for BioPharma market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CRO Services for BioPharma and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CRO Services for BioPharma.

United States market for CRO Services for BioPharma is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for CRO Services for BioPharma is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for CRO Services for BioPharma is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key CRO Services for BioPharma players cover PPD (Thermo Fisher), Space Peptides, Aurigene Pharmaceutical Services, IQVIA, Labcorp Drug Development, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of CRO Services for BioPharma market by product type, application, key players and key regions and countries.

Segmentation by Type:
Preclinical CRO
Clinical Trial CRO

Segmentation by Application:
Commercial
Scientific Research
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Preclinical CRO
Clinical Trial CRO

Segmentation by Application:
Commercial
Scientific Research
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
PPD (Thermo Fisher)
Space Peptides
Aurigene Pharmaceutical Services
IQVIA
Labcorp Drug Development
Parexel
ICON plc
Syneos Health
Charles River Laboratories
Medpace
SGS SA
KCR CRO
TFS HealthScience
Caidya
Worldwide Clinical Trials
CTI
Advanced Clinical
WuXi AppTec
Pharmaron Inc.
Hangzhou Tigermed Consulting
JOINN Laboratories
MEDICILON

Please note: The report will take approximately 2 business days to prepare and deliver.